Patrys Limited ( (AU:PAB) ) has issued an announcement.
Patrys Limited announced the cessation of 2,750,000 securities due to the expiry of options or other convertible securities without exercise or conversion as of March 15, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and future growth prospects.
More about Patrys Limited
Patrys Limited operates in the biotechnology industry, focusing on the development of novel antibody therapies for cancer treatment. The company is known for its innovative approach in utilizing the body’s natural immune system to target and destroy cancer cells, positioning itself as a leader in the therapeutic antibody market.
Technical Sentiment Signal: Buy
Current Market Cap: €3.71M
Learn more about PAB stock on TipRanks’ Stock Analysis page.